| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 23, 2007
Accepted on September 17, 2007
Division of Endocrinology, Department of Radiology, Department of Pathology and Laboratory Medicine, and Department of Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and the Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
* To whom correspondence should be addressed. E-mail: stanleyc{at}email.chop.edu.
Objective: Focal lesions in infants with congenital hyperinsulinism represent areas of adenomatosis that express a paternally-derived KATP channel mutation due to embryonic loss of heterozygosity for the maternal 11p region. This study evaluated the accuracy of [18F]-DOPA PET scans in diagnosing focal versus diffuse disease and in identifying the location of focal lesions.
Design: Fifty infants with hyperinsulinism unresponsive to medical therapy were studied. Patients were injected intravenously with [18F]-DOPA and PET scans were obtained for 50–60 minutes. Images were co-registered with abdominal CT scans. PET scan interpretations were compared with histologic diagnoses.
Results: The diagnosis of focal or diffuse hyperinsulinism was correct in 44 of the 50 cases (88%). [18F]-DOPA PET identified focal areas of high uptake of radiopharmaceutical in 18 of 24 patients with focal disease. The locations of these lesions matched the areas of increased [18F]-DOPA uptake on the PET scans in all of the cases. PET scan correctly located 5 lesions that could not be visualized at surgery. The positive predictive value of [18F]-DOPA in diagnosing focal adenomatosis was 100% and the negative predictive value was 81%.
Conclusions: [18F]-DOPA PET scans correctly diagnosed 75% of focal cases and were 100% accurate in identifying the location of the lesion. These results suggest that [18F]-DOPA PET imaging provides a useful guide to surgical resection of focal adenomatosis and should be considered as a guide to surgery in all infants with congenital hyperinsulinism who have medically-uncontrollable disease.
This article has been cited by other articles:
![]() |
W. Barthlen, O. Blankenstein, H. Mau, M. Koch, C. Hohne, W. Mohnike, T. Eberhard, F. Fuechtner, B. Lorenz-Depiereux, and K. Mohnike Evaluation of [18F]Fluoro-L-DOPA Positron Emission Tomography-Computed Tomography for Surgery in Focal Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 869 - 875. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |